Form 4: Paylocity Co-CEO Steven Beauchamp Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Paylocity Holding Corp's Co-Chief Executive Officer, Steven R. Beauchamp, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan on July 22, 2024.
Summary
- On July 22, 2024, Steven R. Beauchamp, Co-Chief Executive Officer of Paylocity Holding Corp, executed a non-qualified stock option to acquire 107,400 shares of common stock at a price of $24.80 per share.
- Simultaneously, Beauchamp sold shares of Paylocity common stock at weighted average prices ranging from $140.62 to $143.88 per share.
- The sales were executed under a pre-arranged 10b5-1 trading plan adopted on August 7, 2023.
- Following these transactions, Beauchamp directly owns 1,745,022 shares of Paylocity common stock and indirectly owns 242,500 shares through the IRIE Family Trust and the IRIE Foundation.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing plan. There is no indication of positive or negative implications for the company.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance. It is common for executives to use 10b5-1 plans to diversify their holdings and manage personal finances.
Comparison to Industry Standards
- Executive compensation and stock option exercises are common practices in publicly traded companies like Paylocity.
- Comparing Beauchamp's transactions to those of executives at similar companies such as Workday or ADP would provide a better understanding of whether these actions are typical.
- The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading, aligning with industry best practices.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the pre-planned nature of the sales.
Key Dates
| Date | Description |
|---|---|
| 08/18/2015 | Date the Non-Qualified Stock Option became exercisable |
| 08/07/2023 | Date the 10b5-1 Plan was adopted by the reporting person |
| 08/18/2024 | Expiration date of the Non-Qualified Stock Option |
| 07/22/2024 | Date of the stock option exercise and share sales |
| 07/24/2024 | Date of the signature on the SEC Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.